Kathryn Beal

Dr. Kathryn Beal is a board-certified radiation oncologist at Memorial Sloan Kettering Cancer Center. She is chief of the brain tumor service within the Department of Radiation Oncology at MSKCC where she trained as a resident and has been on staff for more than 15 years. Dr. Beal received her BA from Harvard College, then received her medical degree from the College of Physicians and Surgeons at Columbia University, and completed her residency in Radiation Oncology at Memorial Sloan Kettering Cancer Center where she was also elected Chief Resident.

Following residency, Dr. Beal joined the staff at Memorial Sloan Kettering Cancer Center and is now the director of the brain tumor program in the Department of Radiation Oncology. She is involved with a number of treatment protocols of radiation therapy for brain tumors as well as imaging of brain tumors as related to radiation therapy planning and treatment response. She was awarded an R21 grant to investigate the use of “18F-Fluorocholine (18F-FCho) to distinguish necrosis from recurrence in brain metastases.” She personally treats ~200 brain metastases patients per year with stereotactic radiosurgery and manages these patients long-term.

Dr. Beal has published and presented several original studies that demonstrate a change in response and improved outcomes in patients treated with the combination of SRS and immunotherapy and has become a leader in this emerging field.

Prior to her medical career, she worked in healthcare management consulting, primarily focusing on hospital operations.